Press Release: GOSS FINAL DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS
SAN FRANCISCO, May 31, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) and an executive, seeking to represent investors who purchased or otherwise acquired Gossamer securities between June 16, 2025 and February 20, 2026.
PHILADELPHIA and VANCOUVER, British Columbia, May 31, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced the pricing of a best-efforts offering of 1,449,300 common shares. Each common share is being sold at an…
MANILA, Philippines, June 01, 2026 (GLOBE NEWSWIRE) -- The Coalition of Asia Pacific Harm Reduction Advocates (CAPHRA) has released a position paper calling on policymakers across the Asia Pacific region to adopt a formal inclusion standard for all significant public health and tobacco control policy work. The paper argues that policies designed without meaningful input…
NEW YORK, May 31, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against POET Technologies Inc. (NASDAQ: POET) and certain of its officers.
NEW YORK, NY, May 31, 2026 (GLOBE NEWSWIRE) -- NEWMEDIA.COM today released new analysis examining why many organizations are moving away from fragmented digital marketing structures and toward integrated AI Visibility Operating Systems designed to coordinate discoverability, authority, conversion optimization, analytics infrastructure, and AI-era search visibility into unified growth systems.
